Nirmatrelvir/ritonavir
Nirmatrelvir/ritonavir (pronunciation: nir-ma-trel-vir/ri-to-na-vir) is a combination of two antiviral medications used in the treatment of COVID-19.
Etymology
The name "Nirmatrelvir" is derived from the names of the two active ingredients in the medication: Nirmatrelvir and Ritonavir. The "/ritonavir" part of the name indicates that the medication is a combination of these two drugs.
Usage
Nirmatrelvir/ritonavir is used in the treatment of COVID-19, a disease caused by the SARS-CoV-2 virus. It works by inhibiting the virus's ability to replicate within the body, thereby reducing the severity of the disease.
Related Terms
- Antiviral medication: A type of drug used to treat viral infections. Nirmatrelvir/ritonavir is an example of an antiviral medication.
- COVID-19: The disease that Nirmatrelvir/ritonavir is used to treat.
- SARS-CoV-2: The virus that causes COVID-19.
See Also
- Pfizer: The pharmaceutical company that developed Nirmatrelvir/ritonavir.
- Viral replication: The process by which viruses reproduce, and which Nirmatrelvir/ritonavir works to inhibit.
External links
- Medical encyclopedia article on Nirmatrelvir/ritonavir
- Wikipedia's article - Nirmatrelvir/ritonavir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski